fluphenazine has been researched along with idazoxan in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, WW; Litman, RE; Pickar, D; Potter, WZ; Su, TP; Weissman, EM | 1 |
| Hong, WW; Hsiao, JK; Litman, RE; Pickar, D; Potter, WZ; Su, TP; Weissman, EM | 1 |
| Hong, WW; Litman, RE; Pickar, D; Potter, WZ; Su, TP | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
3 trial(s) available for fluphenazine and idazoxan
| Article | Year |
|---|---|
Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Dioxanes; Double-Blind Method; Drug Therapy, Combination; Female; Fluphenazine; Humans; Idazoxan; Male; Pilot Projects; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1993 |
Clinical response to clozapine in patients with schizophrenia.
Topics: Clozapine; Dioxanes; Double-Blind Method; Drug Therapy, Combination; Fluphenazine; Hospitalization; Humans; Idazoxan; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1994 |
Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine.
Topics: Adrenergic alpha-Antagonists; Adult; Antipsychotic Agents; Clozapine; Dioxanes; Double-Blind Method; Drug Therapy, Combination; Female; Fluphenazine; Humans; Idazoxan; Imidazoles; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1996 |
1 other study(ies) available for fluphenazine and idazoxan
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |